Supha Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/03/2026 ,inter alia, to consider and approve To consider Un-Audited Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Supha Pharmachem Ltd has postponed its Board meeting, originally scheduled for 14 February 2026, to 30 March 2026. The meeting will consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended 31 December 2025. The reason for the delay is non-availability of financial information from its overseas subsidiary in Singapore, which is required to finalise the consolidated results. The trading window for insiders remains closed from 1 January 2026 and will reopen 48 hours after the results are declared.
The repeated delay in announcing Q3 results, especially due to subsidiary-related issues, may concern investors about reporting efficiency and overseas operations. However, the rescheduled date is now confirmed, and results should be available by 30 March 2026.